A novel risk calculator developed by researchers at the Cleveland Clinic encourages patients with both type 2 diabetes and obesity to weigh their treatment options for optimal long-term health.

A study published in Hypertension this month has found that exercise—historically one of our best first-line defenses against cardiovascular disease—could also negatively impact heart health in certain situations, including at work.

Finalized results from the OSLER-1 trial—the longest-running study of PCSK9 inhibitors to date—suggest evolocumab is safe and “consistently excellent” at lowering LDL-cholesterol through five years.

Bulimia nervosa places women at a significantly greater risk of CVB and death than women who have not been diagnosed with the condition, a JAMA Psychiatry study reveals.

The largest study of its kind has found that taking blood pressure medication at bedtime—as opposed to first thing in the morning—lowers heart patients’ risk of death and CV-related illness in the long run.

Women who breastfeed for more than one year may be less likely to develop diabetes and hypertension.

Weight gain during early training causes cardiovascular problems for collegiate football players.

Pregnant women may soon be able to assess their own risk of preeclampsia, according to work published in the Journal of Engineering and Science in Medical Diagnostics and Therapy.